WHY BIG PHARMA IS DEAD IN THE WATER—GET READY TO STEP-UP TO THE PLATE
THE WHY
Between 1985 and 1995, Big Pharma sold off its facilities and skilled people that created its products.
When less products came through, it engaged in horizontal M&A activity that cost $BNs but didn’t help—in fact, things got more complex, and most failed.
Then, Big Pharma focussed on rare disease, orphan indications and all things cancer—the volum…